Tatsuhiko Naito, Kosuke Inoue, Shinichi Namba, Kyuto Sonehara, Ken Suzuki, Koichi Matsuda, Naoki Kondo, Tatsushi Toda, Toshimasa Yamauchi, Takashi Kadowaki, et al. Machine learning reveals heterogeneous associations between environmental factors and cardiometabolic diseases across polygenic risk scores. Communications Medicine. 2024. 4. 1
Takafumi Ojima, Shinichi Namba, Ken Suzuki, Kenichi Yamamoto, Kyuto Sonehara, Akira Narita, Yoichiro Kamatani, Gen Tamiya, Masayuki Yamamoto, Toshimasa Yamauchi, et al. Body mass index stratification optimizes polygenic prediction of type 2 diabetes in cross-biobank analyses. Nature Genetics. 2024
Takayoshi Sasako, Ken Suzuki, Sara Odawara, Hirotsugu Suwanai, Naoko Akuta, Naoto Kubota, Kohjiro Ueki, Takashi Kadowaki, Toshimasa Yamauchi. Corticosteroid-triggered acute skeletal muscle loss in lipodystrophy: A case report. Journal of diabetes investigation. 2024
Ken Suzuki, Konstantinos Hatzikotoulas, Lorraine Southam, Henry J Taylor, Xianyong Yin, Kim M Lorenz, Ravi Mandla, Alicia Huerta-Chagoya, Giorgio E M Melloni, Stavroula Kanoni, et al. Genetic drivers of heterogeneity in type 2 diabetes pathophysiology. Nature. 2024
Ken Suzuki, Konstantinos Hatzikotoulas, Lorraine Southam, Henry J Taylor, Xianyong Yin, Kim M Lorenz, Ravi Mandla, Alicia Huerta-Chagoya, Nigel W Rayner, Ozvan Bocher, et al. Multi-ancestry genome-wide study in >2.5 million individuals reveals heterogeneity in mechanistic pathways of type 2 diabetes and complications. medRxiv : the preprint server for health sciences. 2023
Jun Hosoe, Hiroko Kadowaki, Fuyuki Miya, Katsuya Aizu, Ichiro Miyata, Tomoyuki Kawamura, Kenichi Satomura, Takeru Ito, Ken Suzuki, Tat-Suhiko Tsunoda, et al. Severe Insulin Resistance Caused by Mutations in INSR: Genotype-Phenotype Correlations and Structural Characterization of the Mutations. DIABETES. 2017. 66. A370-A370
Yuta Hiraike, Hironori Waki, Jing Yu, Masahiro Nakamura, Kana Miyake, Ken Suzuki, Ryo Nakaki, Gaku Nagano, Haruya Ohno, Kenji Oki, et al. NFIA Controls the Brown Fat Gene Program by Colocalizing with PPARgamma at Cell-Type-Specific Enhancers. DIABETES. 2017. 66. A67-A67
Yuta Hiraike, Hironori Waki, Jing Yu, Masahiro Nakamura, Kana Miyake, Ken Suzuki, Ryo Nakaki, Wei Sun, Tomohisa Aoyama, Yusuke Hirota, et al. NFIA Controls the Brown Fat Gene Program by Co-Localizing with PPARgamma at Cell Type-Specific Enhancers. DIABETES. 2016. 65. A441-A441